5AM Ventures Closes $750 Million Across Two Life Science Funds and Announces Team AdditionsApr 4, 2022
Wildcat Discovery Signs Joint Development Agreement with BMW Group to Speed Next Generation Battery Technology to the MarketJan 18, 2023
Dianthus Therapeutics Strengthens Leadership Team with Appointment of Susan Kalled, Ph.D., as Chief Scientific OfficerJan 18, 2023
Pear Therapeutics and Coeus Healthcare Partner to Combat the Addiction Crisis with Prescription Digital TherapeuticsJan 10, 2023
Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual MeetingNov 14, 2022